Skin

Adverse Effects of Engineered Nanomaterials

Volumn , Issue , 2012, Pages 185-207

  Monteiro Riviere, Nancy A ^a   Filon, Francesca Larese ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879233315     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-386940-1.00011-8     Document Type: Chapter

References (130)

1. Monteiro-Riviere N.A. Comparative anatomy, physiology, and biochemistry of mammalian skin. Dermal and ocular toxicology fundamentals and methods 1991, 3-71. CRC Press, Boca Raton. D.W. Hobson (Ed.).
2. Monteiro-Riviere N.A. The integument. Dellmann's textbook of veterinary histology 2006, 320-349. Blackwell Publishing, Ames. 6th ed. J. Eurell, B. Frappier (Eds.).
3. Monteiro-Riviere N.A. Structure and function of skin. Toxicology of the skin-target organ series 2010, Vol. 29:1-18. Informa Healthcare, New York. N.A. Monteiro-Riviere (Ed.).
4. Cork M.J., Robinson D.A., Vasilopoulos A., et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene-environment interactions. J Allergy Clin Immunol 2006, 118:3-21.
5. Monteiro-Riviere N.A., Bristol D.G., Manning T.O., Riviere J.E. Interspecies and interregional analysis of the comparative histological thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species. J Invest Dermatol 1990, 95:582-586.
6. Holbrook K., Odland G. Regional differences in the thickness (cell layers) of the human stratum corneum: An ultrastructural analysis. J Invest Dermatol 1974, 62:415-422.
7. Menten D.A. A minimum surface mechanism to account for the organization of cells into columns in the mammalian epidermis. Am J Anat 1976, 145:1-22.
8. Menten D.A. Liquid film model of tetrakaidecahedral packing to account for the establishment of epidermal cell columns. J Invest Dermatol 1976, 66:283-291.
9. Landmann L. Epidermal permeability barrier: Transformation of lamellar granule-disks into intercellular sheets by a membrane-fusion process, a freeze-fracture study. J Invest Dermatol 1986, 87:202-209.
10. Swartzendruber D.C., Wertz P.W., Madison K.C., Downing D.T. Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol 1987, 88:709-713.
11. Swartzendruber D.C., Wertz P.W., Kitko D.J., Madison K.C., Downing D.T. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. J Invest Dermatol 1989, 92:251-257.
12. Madison K.C., Swartzendruber D.C., Wertz P.W. Presence of intact intercellular lipid lamellae in the upper layers of the stratum corneum. J Invest Dermatol 1987, 88:714-718.
13. Menon G.K., Feinfold K.R., Elias P.M. The lamellar secretory response to barrier disruption. J Invest Dermatol 1992, 98:279-289.
14. Elias P.M. Epidermal lipids, barrier function and desquamation. J Invest Dermatol 1983, 80:44s-49s.
15. Elias P.M. Defensive functions of the stratum corneum: Intergrative aspects. Toxicology of the skin-target organ series 2010, Vol. 29:19-28. Informa Healthcare, New York. N.A. Monteiro-Riviere (Ed.).
16. Elsner P. Irritant dermatitis in the workplace. Dermatol Clin 1994, 12:461-467.
17. Fluhr J.W., Dickel H., Kuss O., Weyher I., Diepgen T.L., Berardesca E.I. Impact of anatomical location on barrier recovery, surface pH and stratum corneum hydration after acute barrier disruption. Br J Dermatol 2002, 146:770-776.
18. Monteiro-Riviere N.A., Inman A.O., Mak V., Wertz P., Riviere J.E. Effect of selective lipid extraction from different body regions on epidermal barrier function. Pharm Res 2001, 18:992-998.
19. Monteiro-Riviere N.A. Anatomical factors that affect barrier function. Dermatotoxicology 2008, 39-50. CRC Press, New York. 7th ed. H. Zhai, K.P. Wilhelm, H.I. Maibach (Eds.).
20. Roberts M.S., Gierden A., Riviere J.E., Monteiro-Riviere N.A. Solvents and vehicle effects on the skin. Dermal absorption and toxicity assessment 2008, 433-447. Informa Healthcare, New York. 2nd ed. M.S. Roberts, K.A. Walters (Eds.).
21. Larese Filon F., D'Agostin F., Bovenzi M., et al. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 2009, 255:33-37.
22. Larese Filon F., Crosera M., Adami G., Bovenzi M., Rossi F., Maina G. Human skin penetration of gold nanoparticles through intact and damaged skin. Nanotoxicology 2011, online 1-9 DOI 10.3109/ 1743390. 2010.551428.
23. Fiserova-Bergerova V., Pierce J.T., Droz P.O. Dermal absorption potential of industrial chemicals: Criteria for skin notation. Am J Ind Med 1990, 17:617-635.
24. Nielsen J.B., Grandjean P. Criteria for skin notation in different countries. Am J Ind Med 2004, 45:275-280.
25. Sartorelli P., Ahlers H.W., Alanko K., et al. How to improve skin notation. Position paper from a workshop. Regul Toxicol Pharmacol 2007, 49:301-307.
26. Monteiro-Riviere N.A., Baroli B. Nanomaterial penetration. Toxicology of the skin-target organ series 2010, Vol. 29:333-346. Informa Healthcare, New York. N.A. Monteiro-Riviere (Ed.).
27. Lansdown A.B., Taylor A. Zinc and titanium oxides: Promising UV-absorbers but what influence do they have on the intact skin?. Int J Cosmet Sci 1997, 19:167-172.
28. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 2006, 91:159-165.
29. Baroli B., Ennas M.G., Loffredo F., Isola M., Pinna R., Lopez-Quintela A. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 2007, 127:1701-1712.
30. Scheuplein R.J. Mechanisms of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol 1967, 48:79-88.
31. Riviere J.E. Absorption and distribution. Introduction to biochemical toxicology 1994, 11-49. Appleton & Lange Publishers, CT. 2nd ed. E. Hodgson, P.R. Levi (Eds.).
32. Monteiro-Riviere N.A., Riviere J.E. Interaction of nanomaterials with skin: Aspects of absorption and biodistribution. Nanotoxicology 2009, 3:188-193.
33. Riviere J.E., Monteiro-Riviere N.A. Toxicokinetics: Dermal exposure and absorption of chemicals and nanomaterials. Comprehensive toxicology 2010, Vol. 1:111-122. Elsevier, New York. 2nd ed. C. McQueen (Ed.).
34. Tinkle S.S., Antonini J.M., Rich B.A., et al. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 2003, 111:1202-1208.
35. Rouse J.G., Yang J., Ryman-Rasmussen J.P., Barron A.R., Monteiro-Riviere N.A. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett 2007, 7:155-160.
36. Filon F.L., Boeninger M., Maina G., Adami G., Spinelli P., Damian A. Skin absorption of inorganic lead and the effects of skin cleansers. J Occup Environ Med 2006, 48:692-699.
37. Nielsen J.B., Nielsen F., Sørensen J.A. Defense against dermal exposures is only skin deep: Significantly increased penetration through slightly damaged skin. Arch Dermatol Res 2007, 299:423-431.
38. Vermula P.K., Anderson R.R., Karp J.M. Nanoparticles reduce nickel allergy by capturing metal ions. Nat Nanotechnol 2011, 5:291-295.
39. Bronaugh RL. Skin penetration of nanoparticles. Proceedings of PPP2008, Perspectives in percutaneous penetration, La Grande Motte; 25-29th of March, 2008. p. 1.
40. Chen X., Schluesener H.J. Nanosilver: A nanoproduct in medical application. Toxicol Lett 2008, 176:1-12.
41. Nanotechnology White Paper. Prepared for the US Environmental Protection Agency by members of the Nanotechnology Workgroup, a group of EPA's Science Policy Council 2007, EPA, US Environmental Protection Agency, Washington, DC.
42. Progress Toward Safe Nanotechnology in the Workplace-A Report from the NIOSH Nanotechnology Research Center, DHHS (NIOSH) 2007, NIOSH, National Institute for Occupational Safety and Health, Publication No. 2007-123, available on line. http://www.cdc.gov/niosh.
43. Roco M.C. Environmentally responsible development of nanotechnology. Environ Sci Technol 2005, 39:106A-112A.
44. Gwinn M.R., Vallyathan V. Nanoparticles: health effects-pros and cons. Environ Health Perspect 2006, 114:1818-1825.
45. Kielhorn J, Melching-Kollmuβ S, Mangelsdorf I. World Health Organization (WHO), environmental health criteria 235 dermal absorption. 2006.
46. Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839.
47. Preliminary opinion on safety of nanomaterials in cosmetic products 2007, SCCP-Scientific Committee on Consumer Products, European Commission, Brussels, Belgium. http://ec.europa.eu/health/archive/ph_risk/committees/04_sccp/docs/sccp_ o_123.pdf.
48. Donaldson K., Aitken R., Tran L., et al. Carbon nanotubes: A review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006, 92:5-22.
49. Geiser M., Schurch S., Gehr P. Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer. J Appl Physiol 2003, 94:1793-1801.
50. Geys J., Coenegrachts L., Vercammen J., et al. In vitro study of the pulmonary translocation of nanoparticles: a preliminary study. Toxicol Lett 2006, 160:218-226.
51. Lam C.W., James J.T., McCluskey R., Hunter R.L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004, 77:126-134.
52. Limbach L.K., Wick P., Manser P., Grass R.N., Bruinink A., Stark W.J. Exposure of engineered nanoparticles to human lung epithelial cells: Influence of chemical composition and catalytic activity on oxidative stress. Environ Sci Technol 2007, 41:4158-4163.
53. Magrez A., Kasas S., Salicio V., et al. Cellular toxicity of carbon-based nanomaterials. Nano Lett 2006, 6:1121-1125.
54. Muller J., Huaux F., Moreau N., et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 2005, 207:221-231.
55. Nel A., Xia T., Mädler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
56. Oberdörster G., Maynard A., Donaldson K., et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part Fibre Toxicol 2005, 2:8. and ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group.
57. Rotoli B.M., Bussolati O., Bianchi M.G., et al. Non-functionalized multi-walled carbon nanotubes alter the paracellular permeability of human airway epithelial cells. Toxicol Lett 2008, 178:95-102.
58. Shimada A., Kawamura N., Okajima M., Kaewamatawong T., Inoue H., Morita T. Translocation pathway of the intratracheally instilled ultrafine particles from the lung into the blood circulation in the mouse. Toxicol Pathol 2006, 34:949-957.
59. Shvedova A.A., Kisin E.R., Mercer R., et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005, 289:L698-L708.
60. Monteiro-Riviere N.A., Inman A.O., Ryman-Rasmussen J.P. Dermal effects of nanomaterials. Nanotoxicology: Characterization, Dosing, and Health Effects 2007, 317-338. Informa Healthcare, New York. N.A. Monteiro-Riviere, C.L. Tran (Eds.).
61. Zhang L.W., Monteiro-Riviere N.A. Assessment of quantum dot penetration into intact, tape stripped, abraded and flexed rat skin. Skin Pharmacol Physiol 2008, 21:166-180.
62. Zhang L.W., Yu W.W., Colvin V.L., Monteiro-Riviere N.A. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol 2008, 228:200-211.
63. Riviere J.E., Brooks J.D. Predicting skin permeability from complex chemical mixtures. Toxicol Appl Pharmacol 2005, 208:99-110.
64. Riviere J.E., Brooks J.D. Predicting skin permeability from complicated chemical mixtures: Dependency of quantitative structure permeability relationships (QPSR) on biology of skin models used. Toxicol Sci 2011, 119:224-232.
65. Rouse J.G., Haslauer C.M., Loboa E.G., Monteiro-Riviere N.A. Cyclic tensile strain increases interactions between human epidermal keratinocytes and quantum dot nanoparticles. Toxicol In Vitro 2008, 22:491-497.
66. Monteiro-Riviere N.A., Inman A.O. Evaluation of quantum dot nanoparticle penetration in human skin. Toxicologist 2008, 102(Suppl. 1):1029.
67. Gulson B., McCall M., Korsch M., et al. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci 2010, 118:140-149.
68. Monteiro-Riviere N.A., Wiench K., Landsiedel R., Schulte S., Inman A.O., Riviere J.E. Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: An in vitro and in vivo study. Toxicol Sci 2011, 123:264-280.
69. 60) topically exposed in industrial organic solvents. Toxicol Appl Pharmacol 2010, 242:29-37.
70. Sapra B., Jain S., Tiwary A.K. Percutaneous permeation enhancement by terpenes: Mechanistic view. AAPS J 2008, 10:120-132.
71. Dos Anjos J.L.V., Alonso A. Terpenes increase the partitioning and molecular dynamics of an amphipathic spin label in stratum corneum membranes. Int J Pharm 2008, 350:103-112.
72. Monteiro-Riviere N.A., Inman A.O., Erdmann D., Xia X., Riviere J.E. Terpene effects on penetration of nanoparticles in human skin. Toxicologist 2011, 120(Suppl. 2):2154.
73. Monteiro-Riviere N.A., Inman A.O. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 2006, 44:1070-1078.
74. Monteiro-Riviere N.A., Yang J., Inman A.O., Ryman-Rasmussen J., Barron A.R., Riviere J.E. Skin penetration of fullerene substituted amino acids and their interactions with human epidermal keratinocytes. Toxicol Sci 2006, 90(Suppl. 1):168.
75. Yu W.W., Chang E., Falkner J.C., et al. Forming biocompatible and nonaggregated nanocrystals in water using amphiphilic polymers. J Am Chem Soc 2007, 129:2871-2879.
76. Prow T.W., Monteiro-Riviere N.A., Inman A.O., et al. Quantum dot penetration into viable human skin. Nanotoxicology 2011, DOI-10.3109/17435390.2011.569092.
77. Lee H.A., Imran M., Monteiro-Riviere N.A., Colvin V.L., Yu W.W., Riviere J.E. Biodistribution of quantum dot nanoparticles in perfused skin: Evidence of coating dependency and periodicity in arterial extraction. Nano Lett 2007, 9:2865-2870.
78. Gopee N.V., Roberts D.W., Webb P., et al. Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci 2007, 98:249-257.
79. Borm P.J.A., Robbins D., Haubold S., et al. The potential risks of nanomaterials: A review carried out for ECETOC. Part Fibre Toxicol 2006, 3:11.
80. Faunce T., Murray K., Nasu H., Bowman D. Sunscreen safety: The precautionary principle, the Australian Therapeutic Goods Administration and nanoparticles in sunscreens. Nanoethics 2008, 2:231-240.
81. Dussert A.S., Gooris E. Characterization of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum. Int J Cosmet Sci 1997, 19:119-129.
82. Gamer A.O., Leibold E., van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro 2006, 20:301-307.
83. Tan M.H., Commens C.A., Burnett L., Snitch P.J. A pilot sudy on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australas J Dermatol 1996, 37:185-187.
84. Lademann J., Weigmann H.J., Rickmeyer C., et al. Penetration of titanium dioxide in sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 1999, 12:247-256.
85. Pflücker F., Wendel V., Hohenberg H., et al. The human stratum corneum layer: An effective barrier against dermal uptake of different forms of topically applied micronized titanium dioxide. Skin Pharmacol Appl Skin Physiol 2001, 14(S1):92-97.
86. Schulz J., Hohenberg H., Pflücker F., et al. Distribution of sunscreens on skin. Adv Drug Deliv Rev 2002, 54(S1):S157-S163.
87. Mavon A., Miquel C., Lejeune O., Payre B., Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and mineral sunscreen. Skin Pharmacol Physiol 2007, 20:10-20.
88. Bennat C., Müller-Goymann C.C. Skin penetration and stabilization of formulations containing microfine titanium dioxide as physical UV filter. Int J Cosmet Sci 2000, 22:271-283.
89. Cross S.E., Innes B., Roberts M., Tsuzuki T., Robertson T.A., McCormick P. Human skin penetration of sunscreen nanoparticles: In-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol 2007, 20:148-154.
90. 2 particles. Toxicol Sci 2010, 115:156-166.
91. 2-penetration in the epidermis of human skin xenografts. Nucl Inst Meth Phys Res B Beam Interact Mater Atoms 2005, 231:280-285.
92. 2 particles at the high energy ion nanoprobe LIPSION. Nucl Inst Meth Phys Res B Beam Interact Mater Atoms 2004, 219-220:82-86.
93. Kiss B., Biró T., Czifra G., et al. Investigation of micronizided titanium dioxide penetration in human skin xenografts and its effect on cellular functions of human skin-derived cells. Exp Dermatol 2008, 17:659-667.
94. Quality of skin as a barrier to ultra-fine particles 2007, NANODERM, Final Report. (Project Number: QLK4-CT-2002-02678). http://www.uni-leipzig.de/%7Enanoderm/.
95. Opinion of the scientific committee on cosmetic products and non-food products intended for consumers concerning titanium dioxide 2000, SCCNFP, European Commission, Brussels, Belgium, Colipa No S 75.
96. Sonavane G., Tomoda K., Sano A., Ohshima H., Terada H., Makino K. In vitro permeation of gold nanoparticles through rat skin and rat intestine: Effect of particle size. Colloids Surf B 2008, 65:1-10.
97. Samberg M.E., Oldenburg S.J., Monteiro-Riviere N.A. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 2010, 118:407-413.
98. Larese Filon F., Adami G., Venier M., et al. In vitro percutaneous absorption of cobalt. Int Arch Environ Health 2004, 77:85-89.
99. Crosera M., Bovenzi M., Maina G., et al. Nanoparticle dermal absorption and toxicity: A review of the literature. Int Arch Occup Environ Health 2009, 82:1043-1055.
100. Kishore A.S., Surekha P., Murthy P.B. Assessment of the dermal and ocular irritation potential of multi-walled carbon nanotubes by using in vitro and in vivo methods. Toxicol Lett 2009, 191:268-274.
101. Eedy D.J. Carbon-fibre-induced airborne irritant contact dermatitis. Contact Dermatit 1996, 35:362-363.
102. Norton S.K., Dellinger Z., Zhou Z., et al. A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release. Clin Transl Sci 2010, 3:158-169.
103. Nelson M.A., Frederick E.D., Bowden G.T., Hooser S.B., Fernando Q., Carter D.E. Effects of acute and subchronic exposure of topically applied fullerene extracts on the mouse skin. Toxicol Ind Health 1993, 9:623-630.
104. Monteiro-Riviere N.A., Inman A.O., Zhang L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 2009, 234:222-235.
105. Yang J., Barron A.R. A new route to fullerene substituted phenylalanine derivatives. Chem Commun (Cambridge) 2004, 24:2884-2885.
106. Colvin V.L. The potential environmental impact of engineered nanomaterials. Nature Biotech 2003, 21:1166-1170.
107. Sayes C.M., Fortner J.D., Guo W., et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 2004, 4:1881-1887.
108. 60, its suspension in water, and its uptake by human keratinocytes. J Am Chem Soc 1994, 116:4517-4518.
109. 60 toxicity in human epidermal keratinocytes. Toxicol Sci 2006, 90(S-1):167.
110. Rouse J.G., Yang J., Barron A.R., Monteiro-Riviere N.A. Fullerene based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol In Vitro 2006, 20:1313-1320.
111. Zhang L.W., Yang J., Barron A.R., Monteiro-Riviere N.A. Endocytic mechanisms and toxicity of a functionalized fullerene in human cells. Toxicol Lett 2009, 191:149-157.
112. Shvedova A.A., Castranova V., Kisin E., et al. Exposure to carbon nanotube material: Assessment of cytotoxicity using human keratinocytes cells. J Toxicol Environ Health 2003, 66:1909-1926.
113. Zhang L.W., Zeng L., Barron A.R., Monteiro-Riviere N.A. Biological interactions of functionalized single-wall carbon nanotubes in human epidermal keratinocytes. Int J Toxicol 2007, 26:103-113.
114. Manna S.K., Sarkar S., Barr J., et al. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kB in human keratinocytes. Nano Lett 2005, 5:1676-1684.
115. Yokoyama A., Sato Y., Nodasaka Y., et al. Biological behavior of hat-stacked carbon nanofibers in the subcutaneous tissue in rats. Nano Lett 2005, 5:157-161.
116. Monteiro-Riviere N.A., Nemanich R.J., Inman A.O., Wang Y.Y., Riviere J.E. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005, 155:377-384.
117. Monteiro-Riviere N.A., Inman A.O., Wang Y.Y., Nemanich R.J. Surfactant effects on carbon nanotube interactions with human epidermal keratinocytes. Nanomed Nanotechnol Biol Med 2005, 1:293-299.
118. Zhang L.W., Monteiro-Riviere N.A. Lectins modulate multi-walled carbon nanotubes cellular uptake in human epidermal keratinocytes. Toxicol In Vitro 2010, 24:546-551.
119. Witzmann F.A., Monteiro-Riviere N.A. Multi-walled carbon nanotube exposure alters protein expression in human keratinocytes. Nanomed Nanotechnol Biol Med 2006, 2:158-168.
120. Witzmann F.A., Monteiro-Riviere N.A. Effect of carbon nanotube exposure on keratinocyte protein expression. Nanotoxicology: Characterization, dosing, and health effects 2007, 197-224. Informa Healthcare, New York. N.A. Monteiro-Riviere, C.L. Tran (Eds.).
121. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol 2007, 127:143-153.
122. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators. Nano Lett 2007, 7:1344-1348.
123. A nanotechnology consumer products inventory 2011, Woodrow Wilson International Center for Scholars. http://www.nanotechproject.org/consumerproducts.
124. Wijnhoven S.W.P., Peijnenburg W.J.G.M., Herberts C.A., et al. Nano-silver: A review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3:109-138.
125. Samberg M.E., Orndorff P.E., Monteiro-Riviere N.A. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology 2011, 5:244-253.
126. Burd A., Kwok C.H., Hung S.C., et al. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen 2007, 15:94-104.
127. Arora S., Jain J., Rajwade J.M., Paknikar K.M. Cellular responses induced by silver nanoparticles: In vitro studies. Toxicol Lett 2008, 179:93-100.
128. Rooney A.D., Jones R.L., Mattie D.R., Schlager J.J., Hussain S.M. In vitro toxicity of nanoparticles in mouse keratinocytes and endothelial cells. United States Air Force Research Laboratory 2004, AFRL-HE-WP-TR-2005-0091.
129. Monteiro-Riviere N.A., Oldenburg S.J., Inman A.O. Interactions of aluminum nanoparticles in human epidermal keratinocytes. J Appl Toxicol 2010, 30:276-285.
130. Exley C., Charles L.M., Barr L., Martin C., Polwart A., Darbre P.D. Aluminium in human breast tissue. J Inorg Biochem 2007, 101:1344-1346.